Viral surface proteins and envelope components (VSPs)

Viral surface proteins and envelope components are the outermost structures of a virus particle that mediate the initial stages of the viral life cycle. These components, primarily glycoproteins embedded in a lipid bilayer or part of a proteinaceous capsid, are responsible for recognizing and binding to specific receptors on the host cell surface [4]. Following attachment, these proteins facilitate the fusion of the viral envelope with the host cell membrane or trigger endocytosis, allowing the viral genome to enter the cytoplasm [5]. Because they are exposed to the host's environment, they are the primary targets for the humoral immune response and the focus of vaccine development and neutralizing antibody therapies [6]. Drugs targeting these components often act as entry inhibitors or fusion inhibitors, preventing the virus from establishing an infection [7]. However, the high mutation rate of many viruses, particularly RNA viruses, leads to rapid evolution of these surface proteins, posing significant challenges for long-term therapeutic efficacy and vaccine design [8]. This entry is marked as incorrect because it represents a broad functional class of proteins across diverse viral families rather than a single, specific molecular target.

Other names

Viral envelope proteinsViral surface glycoproteinsViral attachment proteinsViral coat proteinsSpike proteinsCapsid proteinsSurface antigens

Drugs targeting these components typically function as entry inhibitors, fusion inhibitors, or exit inhibitors. Neutralizing antibodies bind to surface proteins to block receptor interaction or membrane fusion [1]. Neuraminidase inhibitors prevent the release of new virions from the host cell surface [2]. Fusion inhibitors prevent the conformational changes required for the viral envelope to merge with the host cell membrane [3].